Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(3 sites)
United States
Magee Women's Hospital, Pittsburgh, Pennsylvania Presbyterian Hospital, Pittsburgh, Pennsylvania Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania Last updated October 2025